Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.
Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.
The Opportunity:
The Director, Global Value, Access & Pricing – NSCLC develops and drives execution of global value, access, and pricing strategies for assigned NSCLC assets and indications. The role ensures payer, HTA, pricing, and evidence requirements inform clinical development, launch preparation, and lifecycle planning to enable timely, sustainable patient access across priority markets.
The Director serves as a core global GVAP lead on cross-functional teams, translating strategy into evidence, pricing, and launch plans. The role partners closely with HEOR, Clinical Development, Regulatory, Commercial, Finance, Medical Affairs, and Regional Market Access to align global and regional execution.
Key responsibilities:
Develop and drive implementation of global value, access, and pricing strategies for assigned NSCLC assets and indications, including launch sequencing, pricing architecture, reference pricing considerations, and net price corridor management across priority markets.
Lead development of the global value story and payer evidence requirements for assigned NSCLC assets, partnering with HEOR on evidence plans, evidence-gap assessments, and early-advice preparation.
Assess NSCLC competitive dynamics, including line-of-therapy positioning, biomarker-driven access and companion-diagnostic testing considerations, and combination-therapy reimbursement implications.
Lead cross-functional EU Joint Clinical Assessment (JCA) readiness activities, aligned with global JCA strategy and in collaboration with regional Market Access and HEOR teams.
Build and maintain strong relationships with Clinical, Commercial, Regulatory, HEOR, and Medical Affairs functions.
Partner with regional teams on local pricing, reimbursement, and negotiation readiness; synthesize regional insights and risks for global decision-making.
Provide market access input into clinical development programs to optimize endpoints, comparators, and evidence packages for payer and HTA success.
Provide access and pricing analyses and recommendations to lifecycle planning and business development evaluations.
Required Skills, Experience and Education:
Bachelor’s degree required; advanced degree Ph.D., PharmD, MD, or MSc in Health Economics, Public Health, Health Policy, or a related field preferred.
10+ years of relevant experience in market access and pricing, including significant global and/or major-market responsibility.
Strong experience in pricing & reimbursement of oncology products.
Deep understanding of global payer systems and HTA processes across Europe (e.g., NICE and G-BA/AMNOG), Japan, and the United States.
Experience designing and implementing global pricing strategy, including value-based pricing, launch sequencing, and reference pricing mitigation.
Experience with pricing regulations, early pricing analysis, and partnering with affiliates on pricing and reimbursement negotiations.
Demonstrated ability to support clinical development to satisfy payer/HTA evidence needs.
Experience engaging HTA and payer organizations in early advice to inform development and trial strategies.
Preferred Skills:
Strategic and analytical thinking with strong problem-solving skills.
Excellent communication, leadership, and cross-functional collaboration abilities.
Proven track record influencing decisions and driving results in a matrix organization.
Understanding of biomarker-testing access and companion-diagnostic reimbursement.
Fluency in English; additional languages are a plus.
#LI-JW1 #LI-Remote
The base pay salary range for this full-time position for candidates working onsite at our headquarters in Redwood City, CA is listed below. The range displayed on each job posting is intended to be the base pay salary range for an individual working onsite in Redwood City and will be adjusted for the local market a candidate is based in. Our base pay salary ranges are determined by role, level, and location. Individual base pay salary is determined by multiple factors, including job-related skills, experience, market dynamics, and relevant education or training.
Please note that base pay salary range is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.
Revolution Medicines is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital status, medical condition, and veteran status.
Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact [email protected].
We are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with Revolution Medicines. These scams may appear as false job advertisements or unsolicited contacts through communication or chat platforms, email, phone, or text message.
Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process. All legitimate communication from Revolution Medicines will come from an official @revmed.com email address.
If you believe you’ve been contacted by someone impersonating a Revolution Medicines recruiter, please report it to [email protected] so we can share these impersonations with our IT team for tracking and awareness.
Similar Jobs
What you need to know about the Charlotte Tech Scene
Key Facts About Charlotte Tech
- Number of Tech Workers: 90,859; 6.5% of overall workforce (2024 CompTIA survey)
- Major Tech Employers: Lowe’s, Bank of America, TIAA, Microsoft, Honeywell
- Key Industries: Fintech, artificial intelligence, cybersecurity, cloud computing, e-commerce
- Funding Landscape: $3.1 billion in venture capital funding in 2024 (CED)
- Notable Investors: Microsoft, Google, Falfurrias Management Partners, RevTech Labs Foundation
- Research Centers and Universities: University of North Carolina at Charlotte, Northeastern University, North Carolina Research Campus
